½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting

    »¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

    021-54845833/15800441009

    Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

    µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > Ò»¿¹ > Íÿ¹PRKAR2B(Phospho-Ser113)¶à¿Ë¡¿¹Ìå

    ²úÆ·ÖÐÐÄ

    ×îвúÆ·

    • Íÿ¹PRKAR2B(Phospho-Ser113)¶à¿Ë¡¿¹Ìå

      ¹æ¸ñ£º
      ¼Û¸ñ£º£¤
      • Æ·ÅÆ : ͨεÉúÎï
      • Ŀ¼ºÅ : TW21941
      • Ó¦Óà : ½ö¹©¿ÆÑÐʹÓÃ
      • »õÆÚ : ÏÖ»õ
      • ¹æ¸ñ £º100ul/200ul/25ul
    • ÉÌÆ·ÏêÇé
    • ²Î¿¼ÎÄÏ×
    • ˵Ã÷ÊéÏÂÔØ
    • ÉÌÆ·ÆÀÂÛ0
    • Ïà¹Ø²úÆ·


    ÖÐÎÄÃû³Æ£º   Íÿ¹PRKAR2B(Phospho-Ser113) ¶à¿Ë¡¿¹Ìå


    Ó¢ÎÄÃû³Æ£º   Anti-PRKAR2B(Phospho-Ser113) rabbit polyclonal antibody


    ±ð        Ãû£º   PRKAR2; RII-BETA


    Ïà¹ØÀà±ð£º   Ò»¿¹


    ´¢        ´æ£º   Àä¶³£¨-20¡æ£© ±Ü¹â


    ËÞ       Ö÷£º   Rabbit


    ¿¹       Ô­£º    PRKAR2B(Phospho-Ser113)


    ·´Ó¦ÖÖÊô£º   Human Mouse Rat


    ±ê  ¼Ç  Î   Unconjugate


    ¿Ë¡ÀàÐÍ£º    rabbit polyclonal


    ¼¼Êõ¹æ¸ñ

    Background:

    cAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase, which transduces the signal through phosphorylation of different target proteins. The inactive kinase holoenzyme is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits.

    Applications:

    WB

    Name of antibody:

    PRKAR2B(Phospho-Ser113)

    Immunogen:

    Peptide sequence around phosphorylation site of Serine113(R-R-A(p)-S-V) derived from Human PKA-R2¦Â.

    Full name:

    protein kinase, cAMP-dependent, regulatory, type II, beta

    Synonyms£º

    PRKAR2; RII-BETA

    SwissProt:

    P31323

    WB Predicted band size:

    46 kDa

    WB Positive control:

    COS7 cells lysates treated with PMA

    WB Recommended dilution:

    500-1000




    ¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿
    ¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿